Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.
Francesca ArcadipanePierfrancesco FrancoManuela CeccarelliGabriella FurfaroNadia RondiElisabetta TrinoStefania MartiniGiuseppe Carlo IorioMassimiliano MistrangeloPaola CassoniPatrizia RaccaMario MorinoUmberto RicardiPublished in: Asia-Pacific journal of clinical oncology (2017)
Simultaneous integrated boost IMRT and concurrent chemotherapy as per RTOG 0529 protocol seems to be safe and feasible with consistent oncological outcomes and a mild acute and late toxicity profile in anal cancer patients.
Keyphrases
- locally advanced
- high grade
- rectal cancer
- papillary thyroid
- liver failure
- randomized controlled trial
- oxidative stress
- respiratory failure
- drug induced
- squamous cell carcinoma
- radiation therapy
- radical prostatectomy
- young adults
- intensive care unit
- adipose tissue
- hepatitis b virus
- lymph node metastasis
- childhood cancer
- skeletal muscle
- acute respiratory distress syndrome